Regentis Biomaterials Ltd.
No trades
No trades
Compare with Regentis Biomaterials Ltd.
−2.67 USD
−13.65 M USD
0.00 USD
2.48 M
Profile
Sector
Industry
CEO
Ehud Geller
Website
Headquarters
Herzliya
Founded
2004
IPO date
Dec 4, 2025
IPO offer price
8.00 USD
ISIN
IL0012190968
FIGI
BBG01BX2K536
Identifiers
ISIN IL0012190968
Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of RGNT is 1.97 USD — it has decreased by −12.75% in the past 24 hours. Watch Regentis Biomaterials Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Regentis Biomaterials Ltd. stocks are traded under the ticker RGNT.
RGNT stock has fallen by −48.83% compared to the previous week, the month change is a −63.72% fall, over the last year Regentis Biomaterials Ltd. has showed a −73.38% decrease.
RGNT reached its all-time high on Jun 15, 2026 with the price of 15.50 USD, and its all-time low was 1.23 USD and was reached on Jun 8, 2026. View more price dynamics on RGNT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RGNT stock is 17.83% volatile and has beta coefficient of 2.53. Track Regentis Biomaterials Ltd. stock price on the chart and check out the list of the most volatile stocks — is Regentis Biomaterials Ltd. there?
Today Regentis Biomaterials Ltd. has the market capitalization of 11.50 M, it has decreased by −6.99% over the last week.
Yes, you can track Regentis Biomaterials Ltd. financials in yearly and quarterly reports right on TradingView.
RGNT net income for the last half-year is −10.42 M USD, while the previous report showed −3.23 M USD of net income which accounts for 0.00% change. Track more Regentis Biomaterials Ltd. financial stats to get the full picture.
No, RGNT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 10 employees. See our rating of the largest employees — is Regentis Biomaterials Ltd. on this list?
Like other stocks, RGNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Regentis Biomaterials Ltd. stock right from TradingView charts — choose your broker and connect to your account.